FEDERATED HERMES, INC. - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,918,169
-27.1%
388,467
-4.8%
0.03%
-22.0%
Q2 2023$16,350,884
+167.7%
408,058
+172.6%
0.04%
+173.3%
Q1 2023$6,107,788
+351528.6%
149,664
+332486.7%
0.02%
Q4 2022$1,737
-82.6%
45
-76.8%
0.00%
Q3 2022$10,000
-56.5%
194
-51.4%
0.00%
Q2 2022$23,000
-99.6%
399
-99.5%
0.00%
-100.0%
Q1 2022$6,177,000
+26.4%
80,942
-0.4%
0.01%
+55.6%
Q4 2021$4,888,000
+40.5%
81,244
+30.8%
0.01%
+28.6%
Q3 2021$3,479,000
-51.4%
62,132
-47.4%
0.01%
-46.2%
Q2 2021$7,161,000
-26.0%
118,020
-14.5%
0.01%
-31.6%
Q1 2021$9,674,000
-11.5%
138,018
-24.4%
0.02%
-13.6%
Q4 2020$10,932,000
+1.9%
182,680
+2.4%
0.02%
-12.0%
Q3 2020$10,726,000
+96.6%
178,405
+71.5%
0.02%
+78.6%
Q2 2020$5,457,000
+787.3%
104,009
+467.2%
0.01%
+600.0%
Q1 2020$615,000
+491.3%
18,336
+696.9%
0.00%
Q4 2019$104,000
-97.7%
2,301
-98.0%
0.00%
-100.0%
Q3 2019$4,475,000
-55.3%
117,550
-48.9%
0.01%
-54.2%
Q2 2019$10,003,000
+26.5%
230,010
+10.7%
0.02%
+20.0%
Q1 2019$7,910,000
-30.3%
207,837
-21.3%
0.02%
-35.5%
Q4 2018$11,356,000
+25.2%
263,969
+43.0%
0.03%
+47.6%
Q3 2018$9,071,000
+578.0%
184,554
+1122.7%
0.02%
+425.0%
Q4 2014$1,338,000
-8.5%
15,0940.0%0.00%
-20.0%
Q3 2014$1,463,000
+35.0%
15,094
+27.9%
0.01%
+66.7%
Q2 2014$1,084,00011,8040.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders